Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Grant/Award of 10,000 INBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 10,000 | n/a |
| Sep 8, 2026 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 2,500 | $286.6K |
| May 29, 2025 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 15,000 | n/a |
| Aug 26, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 15,188 | $195.8K |
| May 30, 2024 | Inhibrx Biosciences, Inc. (INXB) | Grant/Award | 149,564 | n/a |
| May 30, 2024 | Inhibrx, Inc. (INBX) | Disposition to Issuer | 598,257 | $17.95M |
| Aug 13, 2020 | AllianzGI Equity & Convertible Income Fund (NIE) | Sale | 10,000 | $246.8K |